Fecal transplant FOR GVHD Type d'étude Maladies Groupe Transplant Complications Working Party (TCWP) Type de traitement Allogeneic Investigateur principal Dr. J. Bilinski
A Phase III Randomized, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-8228 (Letermovir) for the Prevention of Clinically Significant Human Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients Type d'étude Clinical Trials Phase I-III Maladies Complications: infectious Groupe Infectious Diseases Working Party (IDWP) Transplant Complications Working Party (TCWP) Type de traitement Investigateur principal
Incidence and outcome of pregnancy following stem cell transplantation Type d'étude Retrospective Studies Maladies Complications: non-infectious Groupe Transplant Complications Working Party (TCWP) Type de traitement Investigateur principal Nina Salooja